F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation

Oncogene. 2000 Aug 10;19(34):3858-65. doi: 10.1038/sj.onc.1203736.

Abstract

We studied the ability of F9 teratocarcinoma cells to arrest in G1/S and G2/M checkpoints after gamma-irradiation. Wild-type p53 protein was rapidly accumulated in F9 cells after gamma-irradiation, however, this was followed not by a G1/S arrest but by a short and reversible delay of the cell cycle in G2/M. In order to elucidate the reasons of the lack of G1/S arrest in F9 cells, we investigated the expression of p53 downstream target Cdk inhibitor p21WAF1/CIP1. In spite of p53-dependent activation of p21WAF1/CIP1 gene promoter and p21WAF1/CIP1 mRNA accumulation upon irradiation, the p21WAF1/CIP1 protein was not detected by either immunoblot or immunofluorescence techniques. However, the cells treated with a specific proteasome inhibitor lactacystin revealed the p21WAF1/CIP1 protein both in non-irradiated and irradiated cells. Therefore we suggest that p21WAF1/CIP1 protein is degraded by a proteasome-dependent mechanism in F9 cells and the lack of G1/S arrest after gamma-irradiation is due to this degradation. We also examined the expression and activity of cell cycle regulatory proteins: G1- and G2-cyclins and cyclin-dependent kinases. In the absence of functional p21WAF1/CIP1 inhibitor, the activity of G1 cyclin/Cdk complexes was insufficiently inhibited to cause a G1 arrest, whereas a decrease of cdc2 and cyclin B1-associated kinase activities was enough to contribute to a reversible G2 arrest following gamma-irradiation. After gamma-irradiation, the majority of F9 cells undergo apoptosis implying that wt-p53 likely triggers pro-apoptotic gene expression in DNA damaged cells. Elimination of defected cells might ensure maintenance of genome integrity in the remaining cell population.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcysteine / analogs & derivatives
  • Acetylcysteine / pharmacology
  • Animals
  • Apoptosis / drug effects
  • CDC2-CDC28 Kinases*
  • Carcinoma, Embryonal / pathology
  • Carcinoma, Embryonal / radiotherapy
  • Cell Cycle / physiology*
  • Cell Cycle / radiation effects*
  • Cyclin B / metabolism
  • Cyclin B1
  • Cyclin D1 / metabolism
  • Cyclin D1 / radiation effects
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclin-Dependent Kinases / metabolism
  • Cyclin-Dependent Kinases / radiation effects
  • Cyclins / genetics
  • Cyclins / metabolism*
  • Cyclins / radiation effects
  • Cysteine Endopeptidases / drug effects
  • Cysteine Proteinase Inhibitors / pharmacology
  • DNA Damage / radiation effects
  • G1 Phase / radiation effects
  • Gamma Rays
  • Mice
  • Multienzyme Complexes / drug effects
  • Nocodazole / pharmacology
  • Promoter Regions, Genetic
  • Proteasome Endopeptidase Complex
  • Protein Serine-Threonine Kinases / metabolism
  • Protein Serine-Threonine Kinases / radiation effects
  • Proto-Oncogene Proteins*
  • S Phase / radiation effects
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Ccnb1 protein, mouse
  • Cdkn1a protein, mouse
  • Cyclin B
  • Cyclin B1
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Cysteine Proteinase Inhibitors
  • Multienzyme Complexes
  • Proto-Oncogene Proteins
  • Tumor Suppressor Protein p53
  • lactacystin
  • Cyclin D1
  • Protein Serine-Threonine Kinases
  • CDC2-CDC28 Kinases
  • Cdk2 protein, mouse
  • Cdk4 protein, mouse
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinases
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • Nocodazole
  • Acetylcysteine